<!DOCTYPE html>
<html lang="en">
<head>
  <meta charset="UTF-8">
  <meta http-equiv="X-UA-Compatible" content="IE=edge">
  <meta name="viewport" content="width=device-width, initial-scale=1.0">
  <link rel="shortcut icon" href="../images/favicon.png" type="image/x-icon">
  <title>Management of Intracranial Infections</title>
  <link href="https://cdn.jsdelivr.net/npm/remixicon@2.5.0/fonts/remixicon.css" rel="stylesheet">
  <link rel="stylesheet" href="../style.css">
  <link rel="stylesheet" href="../notes.css">

</head>
<body>
  <input type="checkbox" id="main-navigation-toggle" class="btn btn--close" title="Toggle main navigation" />
  <label for="main-navigation-toggle">
    <span></span>
  </label>
  
  <a href="../index.html">
   <div class="home-navigation">
      mtr<span class="logo-dot">.</span>
    </div>
  </a>


    <nav id="main-navigation" class="nav-main">
    <ul class="menu">
      <li class="menu__item">
        <a class="menu__link" href="../index.html">Home</a>
      </li>

      <li class="menu__item">
        <a class="menu__link" href="../about-temp2.html">About</a>
      </li>
    </ul>
  </nav>
  
      <!-- Toggle switch for dark mode -->
      <div class="dark-mode-toggle">
        <label class="switch-toggle">
            <input type="checkbox" id="dark-mode-toggle-checkbox">
            <span class="toggle-slider"></span>
        </label>
      </div>

      <!-- Progress Bar  -->
      <div id="progress-container">
        <div id="progress-bar"></div>
    </div>
      
<!-- SIDEBAR -->
<div id="sidebar" class="sidebar">
  <button id="closeSidebarBtn" class="btn toggle-btn close-btn">Close</button>
  <ul class="sidebar-menu toggle-menu">
    <!-- Add the list of topics dynamically using JavaScript -->
  </ul>
</div>

<!-- Toggle button to open the sidebar -->
<button id="toggleSidebarBtn" class="btn toggle-btn">&#9776;</button>

<!-- END OF SIDEBAR -->

  <main class="page-container">
    <div class="contribute-cta">
      <p>Help make this betterüíú</p>
      <span><a href="../contribute.html">Contribute here</a> </span>
    </div>


  <!-- TOPIC AND IMAGE CONTAINER  -->


      <h1>Management of Intracranial Infections</h1>


  <!-- END OF TOPIC AND IMAGE CONTAINER  -->
  


    <article class="notes">
        <a id='top'></a>
    <article>

          <!-- LEARNING OBJECTIVES CONTAINER  -->
              <div class="custom-card" id="custom-card-1">
                <div class="icon"><img src="../images/icons/light-bulb.png" alt="Icon" class="icon"></div>
                <div class="title"> 
                  <h2>What You Will Learn</h2>
                </div>
                <div class="line">
                  <p>After reading this note, you should be able to...</p>
                </div>
                <div class="content">
                  <ul>
                    <li><i>This content is not available yet.</i></li>
                </ul>
                </div>
                <div class="read-more" onclick="toggleContent('custom-card-1')">Read More üç™</div>
              </div>
            
          <!-- END OF LEARNING OBJECTIVES CONTAINER  -->
        
        
          <!-- SHOW AND HIDE OUTLINE CONTAINER  -->
            <div class="outline2">
        
              <input type="radio" name="control-2" id="show-2">
              <label for="show-2">üêµ&nbsp; &nbsp;Show Outline</label>
              <input type="radio" name="control-2" id="hide-2">
              <label for="hide-2">üôà&nbsp; &nbsp; Hide Outline</label>
              <div class="contents">
                <div class="icon-box">
                  <!-- Replace 'path/to/your/icon.png' with the actual path to your PNG icon -->
                  <img src="../images/icons/book.png" alt="Icon" class="icon">
                </div>
                <div id="tableOfContents">
                    <ol id="tocList"></ol>
                </div>
              </div>
             <div>
        
        <!-- END OF SHOW AND HIDE OUTLINE CONTAINER  -->
        
        <br>
        <br>

        
            <!-- BEGINNING OF NOTE -->
        
      <section id='header-1'>
        <header>
          <h2>
            <a aria-hidden='true' href='#header-1'>Introduction</a>
          </h2>
        </header>
        <div class='body'>
            <ul>
              <li><strong>Intracranial infections</strong> include <strong>MENINGITIS, ENCEPHALITIS, VENTRICULITIS, CEREBRAL ABSCESS, EPIDURAL ABSCESS, SUBDURAL EMPYEMA</strong> and present almost always to the emergency room.</li>
              <li>These conditions often require admission to an <strong>ICU</strong> and they have significant morbidity and mortality.</li>
              <li>These could be community-acquired, nosocomial, or could follow neurosurgical procedures (craniotomy, VP shunting, invasive neuromonitoring techniques).</li>
              <li>Reducing morbidity and mortality is critically dependent on rapid diagnosis and timely initiation of appropriate antimicrobial therapy.</li>
            </ul>
            
        </div>
      </section>

      <section id='header-2'>
        <header>
          <h2>
            <a aria-hidden='true' href='#header-2'>Aetiology</a>
          </h2>
        </header>
        <div class='body'>
            <ul>
              <li>Various organisms have been implicated in <strong>CNS infections</strong>:
                <ul>
                  <li><strong>Bacteria</strong></li>
                  <li><strong>Viruses</strong></li>
                  <li><strong>Protozoa</strong></li>
                  <li><strong>Helminthes</strong></li>
                  <li><strong>Prion</strong></li>
                </ul>
              </li>
            </ul>
            
            <h4>Acute Bacterial Meningitis</h4>
            <ul>
              <li><strong>Neonates</strong>: Group B streptococcus, E. coli</li>
              <li><strong>4-12 weeks</strong>: Group B streptococcus, Listeria monocytogenes</li>
              <li><strong>3 months-5 years</strong>: H. Influenzae, S. pneumoniae, N. meningitidis</li>
              <li><strong>Older than 5 years</strong>: S. pneumoniae, N. meningitidis</li>
              <li><strong>Hospital acquired/post neurosurgical</strong>: Staph aureus, mixed infection</li>
            </ul>
            
            <h4>Acute Community Acquired Viral Meningitis</h4>
            <ul>
              <li><strong>Enteroviruses</strong> - most common</li>
              <li><strong>Adenovirus</strong></li>
              <li><strong>Arbovirus</strong></li>
              <li><strong>Herpes Simplex virus</strong></li>
              <li><strong>Varicella Zoster virus</strong></li>
            </ul>
            
            <h4>Encephalitis</h4>
            <ul>
              <li>Encephalitis is an acute inflammation of the brain parenchyma, and it is most commonly caused by viruses such as mumps, herpes simplex virus (<strong>HSV</strong>), cytomegalovirus (<strong>CMV</strong>), varicella zoster virus (<strong>VZV</strong>), enteroviruses, togaviruses (eastern and western equine viruses), and lymphocytic choriomeningitis virus. Other recently emerged viral encephalitis include; West Nile virus (<strong>WNV</strong> - the most common arboviral encephalitis in the US transmitted by mosquitoes) and monkeypox in North America, and Chandipura viruses in the developed world.</li>
              <li>An increase in encephalitis caused by <strong>CMV</strong>, Epstein-Barr virus (<strong>EBV</strong>), and human herpes virus (<strong>HHV</strong>-6) has occurred because of an increase in immuno-compromised states, including <strong>HIV</strong>, organ transplantation, and cancer chemotherapy.</li>
              <li>Other microorganisms that can cause encephalitis include protozoa, such as <strong>Toxoplasma gondii</strong>, and bacteria, such as <strong>Listeria monocytogenes</strong> and <strong>Mycobacterium tuberculosis</strong>.</li>
            </ul>
            
            <h4>Ventriculitis</h4>
            <ul>
              <li>It often complicates meningitis but it can occur as a primary process.</li>
              <li>It is frequently associated with the presence of a <strong>CSF shunt</strong>, external ventricular drainage (<strong>EVD</strong>), or other intracranial device.</li>
              <li>The risk of developing a ventriculitis or meningitis with an <strong>EVD</strong> in place is <strong>10-15%</strong> (and up to <strong>40%</strong>).</li>
              <li>The most common pathogens involved in <strong>EVD</strong> and <strong>CSF shunt infections</strong> are gram-positive organisms, such as <strong>Staphylococcus epidermidis</strong> and <strong>Staphylococcus aureus</strong>.</li>
              <li>As many as <strong>25%</strong> of infections, however, are caused by gram-negative organisms, such as <strong>E. coli</strong>, <strong>Klebsiella spp.</strong>, <strong>Acinetobacter</strong>, and <strong>Pseudomonas spp.</strong></li>
              <li>These organisms should be suspected in patients with a ventriculo-peritoneal shunt, as a result of contamination of the peritoneal end of the catheter.</li>
            </ul>
            
            <h4>Cranial Epidural Abscess</h4>
            <ul>
              <li>The most common infectious etiologies include streptococci, staphylococci, and anaerobes, and infections are often polymicrobial.</li>
            </ul>
            
            <h4>Subdural Abscess</h4>
            <ul>
              <li>Unlike the epidural space, the subdural space is less restrictive, resulting in a wider spread of empyema, which can cause inflammation of the brain parenchyma (when it breaches the subarachnoid space), edema, mass effect, elevated intracranial pressure (<strong>ICP</strong>), septic thrombophlebitis, and venous infarction.</li>
              <li>Subdural empyema is associated with a much more complicated course and worse outcome when compared with epidural abscess.</li>
            </ul>
            
        </div>
      </section>

      <section id='header-3'>
        <header>
          <h2>
            <a aria-hidden='true' href='#header-3'>Aetiopathogenesis</a>
          </h2>
        </header>
        <div class='body'>

            <h4>Pathogenesis</h4>
            <ul>
              <li>Infective microorganisms reach and establish themselves in the <strong>CNS</strong> via one of the following means:
                <ul>
                  <li><strong>Direct Spread</strong>
                    <ul>
                      <li>From infected contiguous structures such as the scalp, nasal cavity, paranasal sinuses, middle ear, and dental apparatus.</li>
                      <li>This is facilitated by retrograde spread through valveless emissary veins.</li>
                    </ul>
                  </li>
                  <li><strong>Haematogenous Spread</strong>
                    <ul>
                      <li>Also described as ‚Äúmetastatic‚Äù spread, if there is an abscess already established elsewhere in the body.</li>
                      <li>Examples include congenital cyanotic heart disease (with right to left shunt), osteomyelitis.</li>
                    </ul>
                  </li>
                  <li><strong>Direct Inoculation</strong>
                    <ul>
                      <li>Following trauma or surgical interventions.</li>
                    </ul>
                  </li>
                </ul>
              </li>
            </ul>
            
        </div>
      </section>

      <section id='header-4'>
        <header>
          <h2>
            <a aria-hidden='true' href='#header-4'>Pathophysiology</a>
          </h2>
        </header>
        <div class='body'>
            <ul>
              <li>Invasive infections of the <strong>CNS</strong> begin with entry of bacteria into the subarachnoid space (or brain parenchyma).</li>
              <li>Bacteria responsible for meningitis attach to the nasopharyngeal epithelium and are nearly all capable of secreting <strong>IgA proteases</strong> that prevent their destruction and allow them to traverse the epithelium and invade the intravascular space. Interactions between the bacterial capsular polysaccharide coat and complement regulatory proteins protect pathogenic bacteria from the complement system, increasing their ability to cross the <strong>blood-brain barrier (BBB)</strong> and enter the <strong>cerebrospinal fluid (CSF)</strong>.</li>
              <li>The <strong>CNS</strong> is an area of impaired host resistance.</li>
              <li>Within the <strong>CNS</strong>, a relatively low concentration of immunoglobulin and weak complement-mediated host defenses enables bacterial replication. Because levels of complements, immunoglobulins, and polymorphonuclear leukocytes are lower in the <strong>CSF</strong> than the serum, opsonic activity is inferior, mandating the use of bactericidal as opposed to bacteriostatic agents.</li>
            </ul>
            

            <h4>Pathophysiology of Cerebral Abscess</h4>
            <ul>
              <li>There are four stages in abscess formation following brain parenchymal inoculation:
                <ul>
                  <li><strong>Early Cerebritis</strong> (Day 1-3)</li>
                  <li><strong>Late Cerebritis</strong> (Day 4-9)</li>
                  <li><strong>Early Capsule Formation</strong> (Day 10-14)</li>
                  <li><strong>Late Capsule Formation</strong> (Beyond day 14)</li>
                </ul>
              </li>
            </ul>
            
            <ul>
              <li>Inoculation of bacteria into brain parenchyma results in focal inflammation and edema (<strong>early cerebritis</strong>) which develops in the first 1-3 days. Typically, there is neutrophil accumulation, edema, and some tissue necrosis. Astrocytes and microglia are activated early on, and this activation persists afterward.</li>
              <li>The area of cerebritis expands and a necrotic center develops (<strong>late cerebritis</strong>) on days 4 to 9. Macrophages and lymphocytes predominate in the infiltrate.</li>
              <li>The <strong>early capsule stage</strong> is characterized by the development of a capsule that is vascularized and ring enhancing on CT scan on days 10-14.</li>
              <li>In the <strong>late capsule stage</strong>, the host immune response causes the capsule to wall off, and there is destruction of some surrounding healthy brain tissue in an attempt to sequester the infection.</li>
            </ul>
            


        </div>
      </section>

      <section id='header-5'>
        <header>
          <h2>
            <a aria-hidden='true' href='#header-5'>Clinical Presentation</a>
          </h2>
        </header>
        <div class='body'>

            <h4>Bacterial Meningitis</h4>
            <ul>
              <li><strong>Symptoms:</strong> <strong>Sensitivity</strong>
                <ul>
                  <li><strong>Fever</strong> - 85%</li>
                  <li><strong>Neck pain/stiffness</strong> - 70%</li>
                  <li><strong>Altered mental status</strong> - 67%</li>
                  <li><strong>Headaches</strong> - 50%</li>
                  <li><strong>Nausea and vomiting</strong> - 30%</li>
                  <li>Photophobia</li>
                </ul>
              </li>
              <li>Highlighted features constitute the classic triad found in 40-45% of cases. About 95% of cases have at least two of the first four symptoms.</li>
            </ul>
            
            <p>Other symptoms include:</p>
            <ul>
              <li>Focal neurologic deficits/nerve palsies including gaze palsies caused by hydrocephalus</li>
              <li>Seizures, 5-28% of cases (indicates cortical irritation, which may be caused by a cortically based complication, e.g., empyema, stroke, or venous thrombosis)</li>

              <li>Coma, from cerebral edema and herniation in the fulminant type</li>
              <li>Multiple cerebral infarcts secondary to vasculitis</li>
              <li>Septic shock (22%)</li>
            </ul>
            
            <p>Other manifestations of meningitis may provide clues to the causative organism:</p>
            <ul>
              <li>Petechial or purpural rash in meningococcal meningitis</li>
              <li>Ataxia and labyrinthitis in <strong>Haemophilus influenzae</strong> meningitis</li>
            </ul>
            

            <h4>Tuberculous Meningitis</h4>
            <ul>
              <li><strong>Cough, weight loss, night sweats, and cranial nerve deficits</strong> in TBM</li>
              <li><strong>Visual impairment or blindness</strong></li>
              <li><strong>Painful ophthalmoplegia</strong></li>
            </ul>
            
            <h4>Viral Encephalitis</h4>
            <ul>
              <li>Clinical presentation often includes a prodrome with <strong>fever, headache, myalgia, and mild respiratory infection</strong>. Altered consciousness with focal neurologic deficits may follow, as well as seizures.</li>
              <li>Specific viruses can have characteristic presentations, such as parotitis associated with <strong>mumps</strong> and herpetic rash with <strong>herpes simplex encephalitis (HSE)</strong>. <strong>Diplopia, dysarthria, and ataxia</strong> can be seen in immunocompromised patients with brainstem HSE.</li>
            </ul>
            
            <h4>Herpes Simplex Encephalitis (HSE)</h4>
            <ul>
              <li>HSE is the most important form of treatable encephalitis. It has a predilection for the temporal and orbitofrontal lobes and results in a clinical picture of <strong>altered consciousness, memory loss, personality change, and confusion or olfactory hallucinations</strong>, following a prodrome of <strong>headache and fever</strong>.</li>
            </ul>
            

            <h4>Brain Abscess, Epidural, and Subdural Empyema</h4>

            <ul>
              <li><strong>Intracerebral/Brain Abscess:</strong>
                <ul>
                  <li>Spread from contiguous structures/post-op incision sites ‚Äì direct and via valve-less veins (face, sinuses, ear infections)</li>
                  <li><strong>Focal neurologic symptoms & signs:</strong> aphasia, paralysis, gait disturbances</li>
                  <li><strong>Classical triad of fever, headaches, neurologic deficit</strong> is present only in 25%</li>
                  <li><strong>Fever</strong> is less common than in meningitis</li>
                </ul>
              </li>
            </ul>

            
            <h4>Pott‚Äôs Puffy Tumor</h4>

            <ul>
              <li><strong>Frontal bone osteomyelitis with sub-periosteal abscess</strong></li>
              <li>Spread from frontal sinusitis, contiguous structures, intracranial abscess</li>
              <li><strong>Fluctuant, tender scalp swelling with erythema</strong></li>
              <li>Described by Percival Pott in 1760</li>
            </ul>
        </div>
      </section>

      <section id='header-6'>
        <header>
          <h2>
            <a aria-hidden='true' href='#header-6'>Investigation</a>
          </h2>
        </header>
        <div class='body'>

            <ul>
              <li><strong>CSF Analysis</strong> through LP, Ventricular tap, or shunt tap</li>
              <li>Avoid LP if raised ICP is suspected (coning!!!)</li>
            </ul>
            
            <ul>
              <li><strong>CSF Biochemistry</strong> (protein and glucose)</li>
              <li><strong>CSF Microscopy, Culture, Sensitivity (MCS)</strong></li>
              <li><strong>CSF AAFB</strong> and Lowenstein Jensen medium culture (Tuberculous meningitis)</li>
              <li><strong>CSF Indian ink test</strong> (Fungal Meningitis)</li>
            </ul>
            
            <table class="note-table">
                <tr>
                  <th>CSF Parameter</th>
                  <th>Normal</th>
                  <th>Bacterial</th>
                  <th>Viral</th>
                </tr>
                <tr>
                  <td>Opening pressure (mm H<sub>2</sub>O)</td>
                  <td>60-180</td>
                  <td>200-500</td>
                  <td><250</td>
                </tr>
                <tr>
                  <td>WBC (/mm¬≥)</td>
                  <td><5</td>
                  <td>>1000</td>
                  <td>50-1000</td>
                </tr>
                <tr>
                  <td>WBC differential</td>
                  <td>-</td>
                  <td>Neutrophils</td>
                  <td>Lymphocytes</td>
                </tr>
                <tr>
                  <td>Glucose (mg/dL)</td>
                  <td>45-80</td>
                  <td><40</td>
                  <td>>40</td>
                </tr>
                <tr>
                  <td>CSF: Blood glucose ratio</td>
                  <td>>0.6</td>
                  <td><0.4</td>
                  <td>>0.6</td>
                </tr>
                <tr>
                  <td>Protein (mg/dL)</td>
                  <td>-</td>
                  <td>100-500</td>
                  <td><200</td>
                </tr>
              </table>
              

              <ul>
                <li><strong>Neuroimaging:</strong> Brain CT Scan or MRI with contrast (may also reveal sinusitis/mastoiditis)</li>
                <li>CT or MR venography should be considered to diagnose complicating cerebral venous sinus thrombosis</li>
                <ul>
                    <li><b>Early cerebritis stage</b></li>
                    <li><b>Acute inflammatory infiltrate</b> with visible bacteria on Gram stain and marked edema surrounding the lesion.</li>
                    <li>No contrast enhancement</li>
                  </ul>

                  <ul>
                    <li><b>late cerebritis stage</b></li>
                    <li>The center of the lesion becomes necrotic,</li>
                    <li>macrophages and fibroblasts invade the periphery.</li>
                    <li>proliferate blood vessel surrounding lesion</li>
                  </ul>
                  <ul>
                    <li><b>early capsule formation</b></li>
                    <li>The center of the lesion becomes necrotic,</li>
                    <li>macrophages and fibroblasts invade the periphery.</li>
                    <li>proliferate blood vessel surrounding lesion</li>
                  </ul>
                  <ul>
                    <li>late capsule formation</li>
                    <li>the collagenous capsule was complete circumferentially</li>
                    <li>increased in density and thickness</li>
                    <li>inner inflammatory layer</li>
                    <li>middle collagenous layer</li>
                    <li>outer gliotic layer</li>
                  </ul>
                  
              </ul>

              <ul>
                <li>Blood cultures in the presence of meningitis are positive in up to <strong>50%</strong> of cases, and a touch preparation of the rash in meningococcal meningitis yields a positive <strong>Gram‚Äôs stain</strong> in <strong>70%</strong> of cases.</li>
                <li><strong>Serum Electrolytes:</strong> Hyponatremia caused by syndrome of inappropriate antidiuretic hormone (<strong>SIADH</strong>) is common in both meningitis and encephalitis.</li>
              </ul>
              
        </div>
      </section>

      <section id='header-7'>
        <header>
          <h2>
            <a aria-hidden='true' href='#header-7'>Treatment </a>
          </h2>
        </header>
        <div class='body'>
            <ul>
              <li><strong>Aggressive treatment</strong></li>
              <li><strong>May need ICU care</strong></li>
              <li><strong>Antibiotic</strong></li>
              <li><strong>Steroid</strong></li>
              <li><strong>+/- anticonvulsant</strong></li>
              <li><strong>Drain abscess</strong></li>
            </ul>
            
            <h4>Meningitis</h4>
            <ul>
              <li>Start antibiotics empirically. A knowledge of prevalent and most likely causative organism is necessary.</li>
              <li>Antibiotic doses are higher for CNS infections (meningitic doses).</li>
            </ul>

            <table class="note-table">
                <tr>
                  <th>Host</th>
                  <th>Pathogens</th>
                  <th>Preferred Abx (see dosing table)</th>
                  <th>Alternative for serious PCN allergy, i.e., anaphylaxis (ID)</th>
                </tr>
                <tr>
                  <td>Immunocompetent, age < 50*</td>
                  <td>S. pneumonia, H. influenzae</td>
                  <td>Ceftriaxone PLUS Vancomycin</td>
                  <td>Vancomycin PLUS Meropenem</td>
                </tr>
                <tr>
                  <td>Immunocompetent, age > 50*</td>
                  <td>S. pneumonia, Listeria monocytogenes, N. meningitidis, H. influenzae Group B streptococcus</td>
                  <td>Ceftriaxone PLUS Ampicillin</td>
                  <td>Vancomycin PLUS Meropenem OR TMP/SMX PLUS Meropenem</td>
                </tr>
                <tr>
                  <td>Immunocompromised*</td>
                  <td>S. pneumonia, N. meningiditis, H. influenzae, Listeria</td>
                  <td>Vancomycin PLUS Cefepime PLUS Ampicillin</td>
                  <td>Vancomycin PLUS Meropenem PLUS TMP/SMX</td>
                </tr>
                <tr>
                  <td>Post-neurosurgery or penetrating head trauma </td>
                  <td>S. pneumo (if CSF leak) H. influenzae, Staphylococci (MRSA, CoNS), Gram-negatives</td>
                  <td>Vancomycin PLUS EITHER Cefepime OR Meropenem</td>
                  <td>Vancomycin PLUS Meropenem</td>
                </tr>

                <tr>
                  <td>Infected Shunt</td>
                  <td>S. aureus, CoNS, P. acnes, gram-negatives (rare)</td>
                  <td>Vancomycin PLUS Cefepime</td>
                  <td>Vancomycin PLUS Meropenem</td>
                </tr>
              </table>
              
              <ul>
                <li>In patients with <strong>HIV infection</strong>, non-bacterial causes of meningitis must be considered, particularly <strong>cryptococcal meningitis</strong>.</li>
              </ul>
              
              <p><strong>Recommended Doses of Select Antimicrobial Agents for Treatment of Meningitis in Adults with Normal Renal and Hepatic Function</strong></p>
              <ul>
                <li>Ampicillin 2 g q4h</li>
                <li>Aztreonam 2 g q6h</li>
                <li>Cefepime 2 g q8h</li>
                <li>Ceftriaxone 2 g q12h</li>
                <li>Ciprofloxacin 400 mg q8h</li>
                <li>Meropenem 2 g q8h</li>
                <li>Metronidazole 500 mg q6h</li>
              </ul>
              
              <p><strong>Duration of Antibiotic therapy</strong></p>
              <ul>
                <li><strong>S. pneumoniae:</strong> 10-14 days</li>
                <li><strong>N. meningiditis, H. influenzae:</strong> 7 days</li>
                <li><strong>Listeria:</strong> 21 days</li>
                <li><strong>Gram-negative bacilli:</strong> 21 days</li>
              </ul>
              

              <h4>Viral Encephalitis</h4>
              <ul>
                <li>Less virulent than bacterial meningitis</li>
                <li>Usually self-limiting (supportive management)</li>
                <li><strong>HSV, VZV:</strong> Acyclovir 10 mg/kg IV q8h for 14-21 days</li>
              </ul>
              
              <h4>Brain/Epidural/Subdural Abscess</h4>
              <ul>
                <li><strong>Antibiotics, drainage +/- anticonvulsant, steroids</strong></li>
                <li>Antibiotics should be adjusted based on culture results.</li>
                <li><strong>Anaerobic coverage should ALWAYS continue even if none is grown.</strong></li>
                <li>IV antibiotics for 2 weeks and oral for 6 weeks</li>
              </ul>
              
              <h4>Use of Dexamethasone</h4>
              <ul>
                <li>Addition of dexamethasone is recommended in all adult patients with suspected pneumococcal meningitis.</li>
                <li><strong>Dose:</strong> 0.15 mg/kg IV q6h for 2-4 days</li>
              </ul>
              
        </div>
      </section>

      <section id='header-8'>
        <header>
          <h2>
            <a aria-hidden='true' href='#header-8'> Conclusion</a>
          </h2>
        </header>
        <div class='body'>
            <ul>
              <li>The management of patients who have CNS infections is challenging.</li>
              <li><strong>Antimicrobial therapy and source control</strong> are keys in management.</li>
              <li>Early management is paramount.</li>
              <li>Long-term antimicrobial treatment.</li>
            </ul>
            
        </div>
      </section>






      <hr style="margin: 3rem 0;">

      <!-- PRACTICE QUESTIONS CONTAINER -->

      <div class="custom-card" id="custom-card-2">
        <div class="icon"><img src="../images/icons/practice-questions.png" alt="Icon" class="icon"></div>
        <div class="title"> 
          <h2>Practice Questions</h2>
        </div>
        <div class="line">
          <p>Check how well you grasp the concepts by answering the following questions...</p>
        </div>
        <div class="content">
          <ol>
            <li><i>This content is not available yet.</i></li>
          </ol>
        </div>
        <div class="read-more" onclick="toggleContent('custom-card-2')">Read More üç™</div>
      </div>

      <!-- END OF PRACTICE QUESTIONS CONTAINER -->


      <!-- CONTACT- COMMENT AND CONTRIBUTORS CONTAINER -->
      <div class="contact">
        <div class="comment-container">
          <div class="comment-icon">
            <!-- Add your icon image here -->
            <img src="../images/icons/comment.png" alt="Comment Icon">
          </div>
          <div class="comment-text">
            <!-- Add your text here -->
            <p>Send your comments, corrections, explanations/clarifications and requests/suggestions </p>
          </div>
          <a href="https://chat.whatsapp.com/FtDdb6uEFYzBCnTnMgm2Z1" class="comment-button">
            here
            <img src="../images/icons/whatsapp.png" alt="Image Icon">
          </a>
        </div>
      </div>

       

            <!-- END OF CONTACT- COMMENT AND CONTRIBUTORS CONTAINER -->
    </article>
   </article>
   <div style="height: 300px;"></div>
  </main>

  <footer>
    <div class="footer-container">
        <div>
          <p id="popup-trigger">disclaimer</p>

          <!-- The pop-up dive content -->
          <div id="popup" class="popup">
            <p>The contents on this ‚Äòwebsite‚Äô are for educational purposes only. The creators and operators of this website make no warranties, express or implied, regarding the accuracy, currency, or completeness of the information provided on the website. They shall not be held responsible for any errors or omissions, or for any actions taken based on the information provided on this website.</p>
            <button class="popup-close" onclick="closePopup()">Close</button>
          </div>    
          <p><a href="../about-temp2.html">about</a> </p>   
          <p><a href="../contribute.html">contribute</a> </p>
          <p><a href="https://chat.whatsapp.com/FtDdb6uEFYzBCnTnMgm2Z1">say hiüëã</a> </p>
        </div>

        <div class="footer-beta">
          <p>thisisatestversion</p>
        </div>
    </div>
  </footer>
<!------------  SCROLL UP ----------->
<a href="#" class="scrollup" id="scroll-up"> 
  <i class="ri-arrow-up-fill scrollup__icon"></i>
</a>
<script src="../main.js"></script>
<script src="../modal.js"></script>
<script src="../notes-sidebar.js"></script>
</body>
</html>
 
